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As the worldwide prevalence of type 2 diabetes continues to rise at an alarming rate, the search for susceptible populations likely to
beneﬁtfrompreventativemeasuresbecomesmoreimportant.Onesuchpopulationiswomenwithaprevioushistoryofgestational
diabetes mellitus (GDM). In this prospective study of 101 women who had GDM in Australia, ethnicity was a major risk factor for
thedevelopmentofdiabetesfollowingadiagnosisofGDM.Withameanfollowupof5.5yearsafterGDM,SouthAsianwomenhad
a signiﬁcantly higher risk of developing abnormal glucose tolerance (AGT) (69%) than women of all other ethnicities (P<0.05).
The prevalence of diabetes and impaired glucose tolerance was also very high amongst other groups: South East and East Asian
(11/27, 41%), Middle-Eastern (8/18, 44%), South European backgrounds (5/12, 42%), and Australian-born women 39% (11/28).
A review of the literature supports the role of ethnicity in the development of diabetes amongst these women. These ﬁndings have
implicationsforSouthAsiancountriesandcountriessuchasAustraliawherethereisapopulationfromdiverseethnicbackgrounds
and where the implementation of targeted measures to stem the growing tide of diabetes is needed.
1.Introduction
Theprevalenceoftype2diabetesisrisingatanalarmingrate.
A recent report by the International Diabetes Foundation
projected that, by 2030, up to 438 million people may be
aﬀected by this disease, accounting for more than 4.5% of
theworld’sprojectedpopulation[1].InChinaalone,arecent
surveyreportedthat92.4millionadults(approximately9.7%
of the nation’s population) have diabetes [2] while another
report estimated that up to 19.4 million individuals living in
the Indian subcontinent were aﬀected [3]. In another “hot
spot,” namely, the Middle East, the prevalence of diabetes
ranges from 13 to 19% amongst 20 to 79 years old in several
countries [4]. The West has not been spared. Studies from
Australia show that the prevalence of diabetes has doubled
from 3.4% in 1981 [5] to 7.4% in 1999-2000 [6].
In the light of these alarming global trends, the search
for eﬀective preventative measures to target individuals at
greatest risk of diabetes is gaining momentum. Women with
a prior history of gestational diabetes mellitus (GDM) rep-
resent one such susceptible population. In fact, the original
criteria for GDM, as deﬁned in 1964, were based on the
likelihood of the mother developing diabetes in later life [7].
GDMaﬀects1.4%to12.3%ofpregnanciesdependingon
the populations tested and the diagnostic criteria used [8].
Recent evidence also suggested that the prevalence of GDM
itself is on the rise, possibly in parallel with the increasing
prevalence of type 2 diabetes. In the Kaiser Permanente
of Colorado Screening Program, the incidence of GDM
doubled from 2.1 to 4.1% amongst 36,403 pregnancies from
1994 to 2002 [9]. Women of various ethnicities including2 ISRN Endocrinology
those from Asian, African American, and Hispanic back-
grounds were twice as likely to experience GDM in this study
as compared to those of non-Hispanic White extraction.
Another study from Australia reported a signiﬁcantly higher
incidence of GDM amongst women who had migrated from
Asian, Middle Eastern, and Mediterranean countries (7.2–
15%)ascomparedtothoseborninAustraliaorNewZealand
(4.3%) [10]. Amongst women attending the antenatal clinic
atourcentrefrom1988 to 1996, wealsoreported a high inci-
dence of GDM amongst migrant women of Chinese (9.5%),
Filipino (6.7%), Sri Lankan (10.5%), and Vietnamese back-
grounds (9.7%) [11]. Therefore, by virtue of their greater
risk of GDM, women from certain ethnicities may be more
susceptible to developing diabetes in the long term.
It is also possible that ethnicity per se may inﬂuence the
subsequent development of diabetes amongst women with
previous GDM. In an indirect comparison of two similarly
designedstudies,62%ofwomenwithahistoryofGDMfrom
Trinidad were subsequently diagnosed with type 2 diabetes
[12] whereas only 3.4% of Swedish women in another study
developed the disease (followup 3–6yrs) [13]. However,
there are relatively few studies directly examining diﬀerences
in the prevalence of diabetes amongst women with previous
GDM pregnancies on the basis of their ethnicity.
Potential ethnic diﬀerences in the development of dis-
ease are also relevant to countries such as Australia where
massive immigration since 1945 has led to the inﬂux of near-
ly 7 million people, a substantial proportion of whom origi-
nate from Asian countries and the region of Oceania (http://
www.immi.gov.au/media/fact-sheets/02key.htm). The dem-
onstration of a particularly high incidence of type 2 diabetes
following an episode of GDM amongst certain ethnic groups
may assist in targeting at-risk individuals for screening and
preventative strategies, thereby potentially lessening the bur-
den of type 2 diabetes in these communities.
To address this issue, we studied two groups of women
with a previous history of GDM, namely, migrant women of
non-Anglo-CelticbackgroundandwomenborninAustralia.
Our aim was to identify diﬀerences in the long-term inci-
dence of impaired glucose tolerance (IGT) or diabetes be-
tween these groups of women that could potentially inﬂu-
ence the public health policy approach towards the growing
tideofdiabetesinourcountry,Asia,theIndiansubcontinent,
and the Middle East.
2.MaterialsandMethods
Study participants were recruited from two centres, namely,
Westmead and Nepean Hospitals, located in western Sydney,
Australia. The catchment area is a demographically diverse
region characterized by a high proportion of foreign-born
residents (21% of the population). The participants were
previously diagnosed with GDM and had attended the ante-
natal clinics at one of these hospitals between 1988 and
1994. Women who had migrated to Australia and were not
from Anglo-Celtic backgrounds were systematically recruit-
ed for study inclusion. These women were further grouped
according to their country of birth under the regions of
South Asia (India, Sri Lanka, and Fijian Indians), Southeast
and East Asia (China, Korea, Singapore, Vietnam, Laos, Phi-
lippines, Malaysia), Southern Europe (Italy, Malta, former
Yugoslavia, Greece), or the Middle East (Egypt, Syria, Iran,
Iraq, Lebanon). A group of women born in Australia was
randomly selected for comparison.
The study protocol was similar to that previously re-
portedbyourcentre[14].Inbrief,medicalrecordsofwomen
with GDM were reviewed and data including the country of
birth, the results of the pregnancy GTT, initial weight and
height, age at the time of conception, family history, and
obstetrichistorywererecorded.Subjectswerethencontacted
by phone and asked if they had developed diabetes, and if
not, if they were willing to be tested, by GTT. Where the
subject declared that she already had diabetes, veriﬁcation
w a sm a d ew i t hh e rl o c a ld o c t o r .
Statistics were performed in SPSS version 14, (Chicago,
IL, USA). Results are presented as mean ± SD. Correlation
between variables was performed by logistic regression ana-
lysis. Comparison of subjects with nonparticipants was ana-
lysed by student’s t-test. P values less than 0.05 were con-
sidered signiﬁcant.
3. Results
We identiﬁed 352 women with GDM from the above-mig-
rant backgrounds. Of these, 191 were not contactable. Of
the remaining 161 subjects, 88 were not interested in par-
ticipating in the study. Therefore, 73 participants remained.
A randomly selected group of 28 Australian-born women
(age 34 ± 4.6yrs) with a previous history of GDM were in-
cluded for comparison.
The mean duration since the subjects’ ﬁrst GDM preg-
nancy, to the time of testing or the development of AGT, was
5.5 years (range 1–12). Of the 73 overseas born women, 24
(33%) had already developed diabetes or were found to have
diabetes upon testing. A further 11 (15%) had IGT. Thus
in total, 48% of these women had either diabetes or IGT
(collectively termed Abnormal Glucose Tolerance, AGT). Of
those with AGT, 17 (49%) were newly diagnosed by recall for
this study (41% with diabetes, 59% IGT).
The mean age at the time of diagnosis of AGT was 35.5±
5.4 years. When examined by region of birth, South Asians
had the highest rate of AGT at 69%, a signiﬁcantly high-
er proportion than the other ethnic groups combined (P =
0.039, Cox-Mantel survival, Figure 1). However, all groups
had a high rate of post-GDM diabetes or impaired glucose
tolerance. Women of Middle-Eastern origin had a 44% risk
of AGT, South Europeans 42%, South East Asians 41%, and
Australian-born women 39%.
Further analysis was performed to examine the relation-
ship of pregnancy factors with the development of AGT
amongst the immigrant women (Table 1). Women who had
developed AGT were 3.9 times more likely to have had
pregnancy-induced hypertension (PIH) during their index
pregnancy, 2.8 times more likely to have required insulin
during that pregnancy, and had higher glucose results at
each time-point during the pregnancy glucose tolerance test.
Women with a subsequent normal (non-GDM) pregnancyISRN Endocrinology 3
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Figure 1: Survival analysis showing the increased progression to
AGT amongst subjects of South Asian extraction versus other wo-
men, P<0.05.
had an odds ratio for developing AGT of 0.2 compared to
women without subsequent normal pregnancy.
On multiple logistic regression analysis of all the signiﬁ-
cant factors listed in Table 1, the GTT result at 2 hours (OR
2.5, 95% CI 1.4–4.5, P = 0.002) and the number of episodes
of GDM (OR 4.0, 95% CI 1.4–11.3, P = 0.008) were inde-
pendent predictors for the development of AGT.
There were also signiﬁcant diﬀerences in anthropometric
variables amongst the ethnic groups (Table 2). South Asians
and South East Asians with AGT were signiﬁcantly lighter
and had lower BMI than those of Middle-Eastern or South
European extraction who had developed AGT (P<0.05
all). Similarly, South East Asians and Caucasians with NGT
were lighter than their Middle-Eastern and South European
counterparts with NGT (P<0.05). Height was not found to
be associated with the development of AGT in the diﬀerent
ethnic groups.
4. Discussion
The risk of diabetes following an episode of GDM is sub-
stantially higher than the baseline risk of diabetes. A recent
meta-analysis of 6 controlled followup studies determined
that the risk of developing diabetes after GDM was 6 times
g r e a t e rt h a ni np a r o u sw o m e nw h oh a dn o ts u ﬀered GDM
(RR 6.0, 95% CI 4.1–8.8) [15]. Furthermore, a considerable
proportion of parous women with diabetes, that is, 10–31%,
would have previously experienced an episode of GDM prior
to the development of frank diabetes [15]. A possible reason
for this is that GDM represents an underlying state of limited
beta-cell reserve that becomes clinically manifest only at a
time of marked insulin resistance, namely, late pregnan-
cy [16]. Therefore, to target this distinct subset of susceptible
women with screening and preventative measures may
potentially lessen the burden of diabetes and have signiﬁcant
public health implications.
Women with previous GDM represent a substantial
proportionofthepopulationthatmaybediﬃculttotargetas
awhole.Thesearchforadditionalfactorsthatwouldindicate
an even greater risk of diabetes amongst women with GDM
may further assist in targeting prevention. Such risk factors
include the use of insulin in pregnancy, high BMI, recurrent
GDM, higher glucose levels in oral glucose tolerance testing,
and fasting hyperglycaemia during pregnancy [14, 17]. Eth-
nicity appears to be a major risk factor. In fact, a review of
theliterature(Table 3)indicatesthatconsistentwiththesere-
sults, women with GDM of Asian background in Western
countries are more likely to subsequently develop diabetes
that women of Anglo-Celtic origin [17–20].
A recent large cohort study of 5470 GDM patients and
783 control subjects reported a signiﬁcantly higher incidence
of diabetes amongst Asian women who had suﬀered GDM
as compared to Caucasian controls over a 9-year period (HR
2.1, 95% CI 1.7–2.7) [17]. In earlier analysis of this cohort,
the two-fold increase in the prevalence of diabetes amongst
Asian versus non-Asian women had become apparent at just
6 months postpartum [18].
Another Australian study found that Vietnamese-born
mothers were signiﬁcantly more likely to develop GDM than
their Australian-born counterparts (7.8% versus 4.3%) [19].
Furthermore, the incidence of diabetes within 9 years after
GDM was substantially higher amongst women born in
Vietnam (25%, 17/68) compared to Australian-born women
(9%, 52/581) [19].
Amongst 221 women in a UK study, 35% of Indo-Asian
subjects had persistent glucose intolerance 3 months post-
partum compared with 7% of Caucasian and 5% of Afro-
Caribbean subjects [20].
In other countries, Latino women and various indige-
nous populations have also been identiﬁed to be at high risk
[21, 22].
As well as a greater incidence of diabetes, women of non-
Englishspeakingbackgroundalsoappeartodevelopdiabetes
within a shorter time following their episode of GDM than
their Anglo-Celtic counterparts [23].
The current study further supports the inﬂuence of eth-
nicity on the incidence of GDM and the subsequent develop-
ment of diabetes. When tested 1–12 years later, 48% of
women of non-Anglo-Celtic migrant backgrounds had de-
veloped abnormal glucose tolerance. Thirty three percent of
patientshaddiabetes,and15%hadIGT.Thiswasincompar-
ison to 39% of Australian-born women who had developed
abnormal glucose tolerance at the time of followup. Women
from South Asian countries were even more likely to develop
diabetes than the other groups. By 8 years, South Asians
displayed a signiﬁcantly higher prevalence of AGT than the
other women. On the whole, the prevalence of diabetes
amongst these women was substantially higher than that of
the general Australian population at the time of the study,
estimated to be in the order of 4–6% in that age group [24].
Itisalsolikelythatwithlongerdurationoffollowup,agreater
proportion of study participants would have developed dia-
betes. In fact, one well-cited study reported a rate of sub-
sequent diabetes of 49.9% over a followup of 22–28 years in
an American population with previous GDM [25].4 ISRN Endocrinology
Table 1: Risk factors for the development of abnormal glucose tolerance following gestational diabetes.
Abnormal glucose
tolerance, N = 35
Normal glucose
tolerance, N = 38
Odds ratio
(95% CI) P value
Family history of DM 51% 39% 1.6 (0.6–4.1) NS
PIH in IP 31% 8% 5.3 (1.3–21.2) 0.02
Macrosomia in IP 20% 24% 0.8 (0.3–2.5) NS
Insulin required in IP 51% 18% 4.5 (1.6–13.1) 0.005
Age at IP 30.8 ±4.73 1 .7 ±4.8 1.0 (0.9–1.1) NS
BMI in IP 27.1 ±6.12 5 .7 ±6.4 1.0 (1.0–1.1) NS
Fasting BSL in IP 5.6 ±1.54 .8 ±0.7 2.8 (1.2–6.6) 0.02
1-hour BSL in IP 11.5 ±2.61 0 .3 ±1.2 1.6 (1.0–2.4) 0.04
2-hour BSL in IP 10.3 ±2.88 .3 ±1.4 2.1 (1.3–3.3) 0.003
GDM episodes 1.6 ±0.71 .3 ±0.6 2.2 (1.0–4.8) 0.04
Subsequent non-GDM pregnancies 0.1 ±0.30 .5 ±0.7 0.2 (0.06–0.6) 0.006
Years after IP 6.7 ±2.76 .0 ±2.1 1.1 (0.9–1.4) NS
Age at followup 37.5 ±5.43 7 .6 ±5.1 1.0 (0.9–1.1) NS
PIH = pregnancy induced hypertension. IP = index pregnancy.
Table 2: Anthropometric and other characteristics of study participants.
South Asian (n = 16) South East Asian (n = 27) Middle-Eastern + South
European (n = 30)
Australian-born (n = 28)
NGT AGT P NGT AGT P NGT AGT P NGT AGT P
Age (yrs) 32.6 ±3.53 1 .4 ±1.60 . 7 6 3 1 .2 ±1.03 0 .6±1.60 . 5 4 3 1 .4 ±1.13 0 .6±1.10 . 6 3 3 1 .6 ±1.33 1 .9±1.40 . 8 0
Weight (kg) 58.2 ±3.26 2 .2 ±4.20 . 4 6 5 2 .7 ±3.36 0 .0±5.50 . 2 8 7 5 .8 ±3.48 3 .8±4.70 . 1 8 7 2 .1 ±3.76 8 .2±4.50 . 8 4
BMI (kg/m2)2 4 .4 ±1.22 5 .4 ±1.20 . 5 9 2 2 .0 ±1.62 4 .4±1.80 . 3 2 2 9 .7 ±1.43 3 ±1.80 . 1 52 9 .7 ±1.43 3 ± 1.80 . 6 1
GTT 0hr
(mmol/L) 5.0 ±0.25 .1 ±0.20 . 5 5 4 .5 ±0.15 .5 ±0.70 . 1 8 5 .1 ±0.26 .3 ±0.5 0.04 5.1 ±0.26 .3 ±0.50 . 9 6
GTT 2hr
(mmol/L) 8.5 ±1.01 0 .1 ±0.50 . 2 1 8 .5 ±0.41 0 .2±1.30 . 2 1 7 .9 ±0.31 0 .5±0.9 0.03 7.1 ±0.31 0 ± 1.00 . 9 9
Parity 1.8 ±10 .6 ±0.20 . 3 4 1 .2 ±0.40 .7 ±0.30 . 3 6 2 .7 ±0.52 .1 ±0.80 . 8 1 0 .88 ±0.31 .1 ±0.30 . 2 2
There were signiﬁcant diﬀerences in anthropometric
parameters, speciﬁcally weight and body mass index,
amongst those from diﬀerent ethnic groups with AGT
(Table 2). South Asians, South East Asians, and Australian-
born women with AGT were signiﬁcantly lighter and had
lower BMIs than their Middle-Eastern and South European
counterparts with AGT (P<0.05 for all), suggesting that
simple obesity is not the only predictor of glucose intoler-
ance. The clinical heterogeneity of those at risk of diabetes is
wellestablishedandrecentguidelineshaverecommendedthe
u s eo fa l t e r n a t eB M Ic u t o ﬀs in the deﬁnition of overweight
and obesity amongst particular ethnic populations, particu-
larly those of Asian extraction [26].
There are limitations to this study. Firstly, as is usually
seen in followup after GDM studies, there was a high rate of
nonparticipation. Women who participated were more likely
to have a positive family history than those who declined to
participate (44% versus 24%, P = 0.04). It is also possible
that participants with a known abnormal glucose tolerance
were more likely to volunteer information about their status.
Women from South-East Asia were more likely to decline to
participate (38% of participants were from SE Asia versus
61% of nonparticipants, P = 0.02). Another limitation was
the lack of systematic recruitment of Australian-born wo-
men, who were a randomly selected group included for com-
parison. Although born in Australia, some of these women
were not of Anglo-Celtic extraction, which would tend to
minimise diﬀerences. However, the numbers were suﬃcient
to demonstrate a signiﬁcantly greater prevalence of diabetes
amongst those from South Asian countries compared to the
combination of women from all other groups, and a very
high rate of AGT overall.
What are some of the potential mechanisms by which
ethnicity might inﬂuence the subsequent development of
type 2 diabetes in those with GDM?
Firstly, genetic factors are likely to play an important
role.Genome-wideassociationstudiesof283Danishwomen
who had suﬀered GDM compared to 2446 glucose-tolerant
controls identiﬁed a number of genetic loci associated with
GDM [27]. The similarity of these loci to those associated
with type 2 diabetes, namely, TCF7L2 and CDKAL1, led the
authorstoproposethatGDMandtype2diabeteswerediﬀer-
ent manifestations of the same genetic entity. However, the
potential impact of particular genetic variants on the sub-
sequentdevelopmentoftype2diabetesinwomenwithGDM
is yet to be determined but merits consideration.ISRN Endocrinology 5
Table 3: Studies comparing the incidence of diabetes amongst Asian versus Anglo-Caucasian with a history of GDM.
Number of participants
with GDM Followup Findings
[17] 5470 9 years Higher incidence of T2DM amongst Asians versus
Caucasians (HR 2.1, 95% CI 1.7–2.7)
[18] 2,957 6 months Higher incidence of T2DM amongst Asians (3.5%)
versus North Europeans (1.2%)
[19] 649 9 years Higher incidence of T2DM amongst Vietnamese-born
(25%) versus Australian-born women (9%)
[20] 221 3 months Higher incidence of IGT amongst Indo-Asians (35%)
versus Caucasians (7%) or Afro-Caribbean (5%)
Possible diﬀerences in the long-term pathophysiological
response to the heightened insulin resistance of pregnancy
may also play a role. A recent study examining 60 hispanic
womenwithrecentGDMwhowerefollowedover52months
reported that the eﬀect of weight gain on the subsequent
risk of type 2 diabetes was secondary to changes in serum
adiponectin levels and the degree of insulin resistance (as
quantiﬁed by the disposition index) [28].
The low participation rate amongst women of Southeast
andEastAsianorigin possibly reﬂectsareducedawarenessof
the risks of GDM and a general lack of information regard-
ing healthy living amongst this population. Language bar-
riers amongst migrants may make the promotion of better
health amongst this population diﬃcult [29]. There are
also speciﬁc cultural and social barriers to healthy lifestyle
that have been identiﬁed in migrant women who have had
GDM [30]. Migrants are also more likely to be socially dis-
advantaged and have lower income than those born locally,
with potential impacts on their overall health [31]. Further-
more, dietary and lifestyle behaviour is largely inﬂuenced by
an individual’s cultural background and these factors may
subsequently inﬂuence the risk of diabetes. In support of
this, a study of Korean women with GDM who consumed
a higher intake of fat calories compared to total calories in
the postpartum period was more likely to develop impair-
ed glucose tolerance and diabetes [32]. In addition, the
change in lifestyle amongst those migrating to Western soci-
eties characterized by high-calorie diets and sedentary life-
styles may play a role, particularly where the underlying sus-
ceptibility to diabetes is high [33].
In public health terms, the high incidence of diabetes
after GDM has the potential to be a major problem for a
countrylikeAustraliawhere20%ofthepopulationisforeign
born [27]. The relatively young age at which migrant women
with GDM developed AGT (i.e., 35.5 years) is also cause for
majorconcernduetothelong-termthreatposedbydiabetes,
its inherent complications, and cost to the health care
economy. Data from the 1990s in US suggest that a reduction
of type 2 diabetes by 25% over 10 years, amongst women
who have had GDM, would save the country $179 million
[34]. Conversely, failure to address this issue will result in a
signiﬁcant human and ﬁnancial cost in the years ahead.
Although prevention is better than cure, the search for
cost-eﬀective and pragmatic preventative measures targeted
at the right population of women with GDM is a challenge.
Todate,therehavebeenonlytwodrugtrialstospeciﬁcallyin-
tervene in women with GDM or a history of GDM to pre-
vent diabetes. In one drug trial to speciﬁcally intervene in
women a history of GDM to prevent diabetes, the use of tro-
glitazone was subsequently discontinued because of reports
of drug-induced hepatotoxicity in other populations [35].
Data from other at-risk groups show that diet and exercise
may reduce the incidence of type 2 diabetes. A Chinese study
demonstrated that intensive dietary or exercise management
over 6 years reduced the likelihood of patients with IGT
developing diabetes by about 40% [36]. Similarly, amongst
males in Japan with IGT, there was a signiﬁcant 67% re-
duction in the incidence of diabetes amongst those who re-
ceived dietary counseling and participated in exercise over
4 years as compared to controls [37]. Another study found
that women who exercised at least once a week were 30%
less likely to develop diabetes than those who were sedentary
[38]. One would predict that such measures might be simi-
larly eﬀective in preventing type 2 diabetes in women who
have had GDM. In the Diabetes Prevention Program, 16%
of the women with impaired glucose tolerance enrolled in
the study had a past history of GDM. Subgroup analysis sug-
gested that both lifestyle intervention and metformin were
eﬀective in preventing progression to diabetes in this cohort
[39].
5. Conclusion
We have found that there is a very high prevalence of ab-
normal glucose tolerance amongst women living in Sydney,
Australia who have had GDM. This presents public health
policymakers a unique opportunity to counter the growing
threat of diabetes by aiming preventative measures at this
high-risk group. However, the challenges faced by such
policies need to be better deﬁned, speciﬁcally the relative
eﬀects of socioeconomic and ﬁnancial inequality, language,
and cultural barriers in the progression of migrant women
from GDM to diabetes. Research examining the preventative
value of exercise and lifestyle modiﬁcation in the prevention
of diabetes amongst women with GDM is also needed to
guide the way forward.
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